PDCD1 and neoplasm: TAM and PD1 blockade can simultaneously modulate the activity of several immune cells: switching from pro–tumour M2 to pro–inflammatory M1 macrophage polarization [26–29], and increasing immune response by dendritic cells (DC) [26, 30] and NK cells [31, 32].